- Home
- RARE vs BB Comparison
RARE vs BB Comparison
Compare RARE & BB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- BB
- Stock Information
- Founded
- RARE 2010
- BB 1984
- Country
- RARE United States
- BB Canada
- Employees
- RARE N/A
- BB N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- BB
- Sector
- RARE Health Care
- BB
- Exchange
- RARE Nasdaq
- BB Nasdaq
- Market Cap
- RARE 3.2B
- BB 2.8B
- IPO Year
- RARE 2014
- BB 1997
- Fundamental
- Price
- RARE $33.00
- BB $4.55
- Analyst Decision
- RARE Strong Buy
- BB Hold
- Analyst Count
- RARE 15
- BB 6
- Target Price
- RARE $87.00
- BB $4.98
- AVG Volume (30 Days)
- RARE 1.4M
- BB 9.4M
- Earning Date
- RARE 11-04-2025
- BB 12-18-2025
- Dividend Yield
- RARE N/A
- BB N/A
- EPS Growth
- RARE N/A
- BB N/A
- EPS
- RARE N/A
- BB N/A
- Revenue
- RARE $630,598,000.00
- BB $536,600,000.00
- Revenue This Year
- RARE $19.65
- BB $2.43
- Revenue Next Year
- RARE $23.65
- BB $7.36
- P/E Ratio
- RARE N/A
- BB N/A
- Revenue Growth
- RARE 20.63
- BB N/A
- 52 Week Low
- RARE $25.81
- BB $2.29
- 52 Week High
- RARE $53.04
- BB $6.24
- Technical
- Relative Strength Index (RSI)
- RARE 52.70
- BB 46.69
- Support Level
- RARE $29.36
- BB $4.44
- Resistance Level
- RARE $35.95
- BB $4.66
- Average True Range (ATR)
- RARE 1.60
- BB 0.17
- MACD
- RARE -0.36
- BB -0.04
- Stochastic Oscillator
- RARE 60.79
- BB 21.00
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.